↓ Skip to main content

Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus

Overview of attention for article published in Cochrane database of systematic reviews, April 2008
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

policy
2 policy sources
twitter
1 tweeter
facebook
1 Facebook page

Citations

dimensions_citation
264 Dimensions

Readers on

mendeley
416 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus
Published in
Cochrane database of systematic reviews, April 2008
DOI 10.1002/14651858.cd006739.pub2
Pubmed ID
Authors

Bernd Richter, Elizabeth Bandeira-Echtler, Karla Bergerhoff, Christian Lerch

Abstract

In type 2 diabetes mellitus there is a progressive loss of beta-cell function. One new approach yielding promising results is the use of the orally active dipeptidyl peptidase-4 (DPP-4) inhibitors like sitagliptin and vildagliptin.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 416 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 5 1%
Germany 1 <1%
Singapore 1 <1%
Spain 1 <1%
Japan 1 <1%
United States 1 <1%
Unknown 406 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 82 20%
Student > Bachelor 51 12%
Researcher 46 11%
Student > Ph. D. Student 44 11%
Student > Postgraduate 31 7%
Other 79 19%
Unknown 83 20%
Readers by discipline Count As %
Medicine and Dentistry 182 44%
Nursing and Health Professions 29 7%
Pharmacology, Toxicology and Pharmaceutical Science 27 6%
Agricultural and Biological Sciences 18 4%
Biochemistry, Genetics and Molecular Biology 14 3%
Other 49 12%
Unknown 97 23%

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 March 2021.
All research outputs
#3,962,142
of 20,568,640 outputs
Outputs from Cochrane database of systematic reviews
#6,439
of 12,078 outputs
Outputs of similar age
#31,742
of 168,246 outputs
Outputs of similar age from Cochrane database of systematic reviews
#46
of 98 outputs
Altmetric has tracked 20,568,640 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,078 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 28.3. This one is in the 46th percentile – i.e., 46% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 168,246 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 98 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.